As featured on Forbes.com, this article discusses the timely shift in gynecological care, driven by new guidelines and innovative tools, to address the often underestimated and poorly managed pain associated with procedures like IUD insertions.

Highlights:

Pain Acknowledged: Recent CDC and ACOG guidelines emphasize better pain management for gynecological procedures, especially IUD insertions.

Carevix® Innovation: Aspivix’s Carevix® is a new, non-traumatic cervical stabilizer using suction, replacing the painful tenaculum to reduce pain and bleeding during IUD insertions.

• Clinical Support: Trials show Carevix® significantly reduces pain and bleeding; U.S. studies are promising, with high patient preference.
• Broader Use: Carevix® and new guidelines apply to various cervical exams and office procedures beyond IUDs.
• Education Focus: Aspivix educates clinicians and empowers women to seek better care, leveraging social media (like a viral TikTok) to raise awareness.
• Industry Trend: Aspivix is part of a larger movement in FemTech, with other companies also developing more comfortable gynecological tools.